Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Methotrexate treatment of idiopathic granulomatous hepatitis

Article Abstract:

Idiopathic granulomatous hepatitis may be effectively treated with low-dose methotrexate. Idiopathic granulomatous hepatitis is a rare disorder involving recurrent liver nodules, fever, fatigue and muscle aches. High-dose glucocorticoids are the usual treatment. Seven patients who could not tolerate or did not respond to glucocorticoid therapy received methotrexate, an immunosuppressive drug. Methotrexate was administered orally, at a dosage of 15 milligrams per week. All seven patients responded well to methotrexate. Fever and fatigue abated, and liver biopsies revealed that granulomatous nodules had disappeared. Mild nausea after methotrexate administration was the only side effect noted. Three patients were able to taper and discontinue methotrexate therapy.

Author: Kaplan, Marshall M., Knox, Tamsin A., Wolff, Sheldon M., Gelfand, Jeffrey A.
Publisher: American College of Physicians
Publication Name: Annals of Internal Medicine
Subject: Health
ISSN: 0003-4819
Year: 1995
Evaluation, Hepatitis

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Sustained biochemical and histologic remission of primary biliary cirrhosis in response to medical treatment

Article Abstract:

Methotrexate treatment appears to be effective in some patients with a liver condition called primary biliary cirrhosis. Liver function and condition were evaluated routinely among five patients treated for at least six years with methotrexate, some of who had previously been treated unsuccessfully with colchicine. These patients were part of a group of 19 similar patients. Liver function and liver condition, as measured by tissue sampling, returned to normal or near normal in all five patients. Other characteristic signs of the condition also disappeared.

Author: Kaplan, Marshall M., DeLellis, Ronald A., Wolfe, Hubert J.
Publisher: American College of Physicians
Publication Name: Annals of Internal Medicine
Subject: Health
ISSN: 0003-4819
Year: 1997
Health aspects, Ursodiol, Biliary cirrhosis, Colchicine

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Reversibility of hepatic fibrosis in autoimmune hepatitis

Article Abstract:

Liver damage associated with autoimmune hepatitis may be reversible. Liver function and liver damage analyses were performed before and after treatment on liver samples from eight patients successfully treated for autoimmune hepatitis. Chemical markers of liver function including bilirubin, alanine aminotransferase, and albumin levels significantly improved with treatment. There was significantly less physical evidence of liver damage and scar tissue formation after treatment.

Author: Kaplan, Marshall M., Dufour, Jean-Francois, DeLellis, Ronald
Publisher: American College of Physicians
Publication Name: Annals of Internal Medicine
Subject: Health
ISSN: 0003-4819
Year: 1997
Prognosis, Liver, Liver cirrhosis, Liver regeneration, Chronic active hepatitis

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Drug therapy, Methotrexate
Similar abstracts:
  • Abstracts: A short-term trial of tacrolimus ointment for atopic dermatitis. Atopic dermatitis
  • Abstracts: Inflammatory arthritis requires Foxo3a to prevent Fas ligand-induced neutrophil apoptosis. Preventing kidney cell suicide
  • Abstracts: Health system reform in the Republic of China: formulating policy in a market-based health system. The Australian health care system: are the incentives Down Under right side up?
  • Abstracts: Factors associated with prolonged hospitalization of children with asthma. A cost-saving algorithm for children hospitalized for status asthmaticus
  • Abstracts: Is there anything left to eat? Health Jeopardy! Winning the weight-loss game. Attack of the killer tomatoes (and other scary headlines.)(nutritional news items; includes related article)
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.